CE and TGA approval as a class II diagnostic medical device..... and IMO, the secondary chronic respiratory management product to monitor the severity of asthma and COPD attacks will be DTC.
Ann: Proposed issue of Securities - RSH, page-164
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
-0.001(3.33%) |
Mkt cap ! $38.54M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.9¢ | $3.885K | 133.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 916020 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 813500 | 5 |
View Market Depth
| Last trade - 11.05am 12/09/2024 (20 minute delay) ? |
| RSH (ASX) Chart |